Adriaan A Voors Selected Research

Spironolactone (Aldactone)

5/2024	Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS-HF trial.
1/2021	Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function.
1/2019	Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease.
1/2015	Finerenone : third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney disease.
9/2014	Effect of spironolactone on 30-day death and heart failure rehospitalization (from the COACH Study).
1/2014	[Spironolactone not effective in diastolic heart failure].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adriaan A Voors Research Topics

Disease

399	Heart Failure 05/2024 - 07/2004
34	Myocardial Infarction 12/2023 - 12/2004
27	Inflammation (Inflammations) 09/2023 - 08/2006
21	Renal Insufficiency (Renal Failure) 01/2023 - 09/2005
18	Atrial Fibrillation 05/2024 - 01/2010
15	Hypertension (High Blood Pressure) 01/2023 - 05/2007
14	Iron Deficiencies 01/2022 - 04/2013
13	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 12/2002
13	Dyspnea (Shortness of Breath) 10/2022 - 01/2010
12	Heart Diseases (Heart Disease) 05/2024 - 10/2013
11	Anemia 11/2021 - 09/2005
10	Stroke (Strokes) 01/2023 - 05/2007
9	Cardiomyopathies (Cardiomyopathy) 04/2024 - 01/2017
9	Weight Loss (Weight Reduction) 01/2023 - 05/2013
9	Systolic Heart Failure 01/2021 - 01/2011
9	Diabetes Mellitus 01/2021 - 03/2012
8	Hypotension (Low Blood Pressure) 04/2024 - 08/2015
8	Fibrosis (Cirrhosis) 09/2023 - 09/2009
7	Necrosis 01/2023 - 12/2011
7	Neoplasms (Cancer) 01/2023 - 09/2009
7	Chronic Renal Insufficiency 01/2022 - 01/2014
7	Left Ventricular Dysfunction 01/2018 - 01/2011
6	Type 2 Diabetes Mellitus (MODY) 04/2024 - 02/2015
6	ST Elevation Myocardial Infarction 04/2024 - 08/2010
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 11/2005
6	Pulmonary Hypertension 11/2021 - 10/2015
6	Body Weight (Weight, Body) 01/2019 - 05/2011
6	Infarction (Infarctions) 10/2013 - 03/2005
5	Hypertrophy 01/2020 - 07/2005
4	Disease Progression 04/2024 - 01/2018
4	Albuminuria 04/2024 - 11/2006
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2023 - 01/2015
4	Obesity 01/2023 - 01/2017
4	Acute Kidney Injury (Acute Renal Failure) 10/2022 - 10/2015
4	Congenital Heart Defects (Congenital Heart Defect) 01/2021 - 07/2006

Drug/Important Bio-Agent (IBA)

68	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2010
65	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2023 - 03/2006
32	DiureticsIBA 05/2024 - 01/2011
31	pro-brain natriuretic peptide (1-76)IBA 05/2024 - 01/2005
25	Erythropoietin FDA Link 10/2021 - 02/2004
24	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 09/2004
23	Natriuretic PeptidesIBA 05/2024 - 01/2005
22	vericiguatIBA 03/2024 - 01/2018
19	CreatinineIBA 04/2024 - 10/2006
17	SodiumIBA 05/2024 - 10/2013
16	Angiotensin Receptor AntagonistsIBA 04/2024 - 07/2007
15	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 11/2023 - 11/2014
14	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 01/2010
14	RelaxinIBA 01/2023 - 04/2009
14	rolofyllineIBA 11/2019 - 05/2011
13	Mineralocorticoid Receptor AntagonistsIBA 05/2024 - 01/2011
13	empagliflozinIBA 04/2024 - 01/2020
12	Urea (Carbamide)FDA LinkGeneric 01/2021 - 09/2013
11	Furosemide (Lasix)FDA LinkGeneric 01/2022 - 05/2011
10	Interleukin-6 (Interleukin 6)IBA 01/2023 - 08/2013
10	Hemoglobins (Hemoglobin)IBA 11/2021 - 04/2005
10	C-Reactive ProteinIBA 01/2021 - 06/2006
10	NitrogenIBA 01/2017 - 09/2013
10	Advanced Glycation End ProductsIBA 11/2012 - 12/2007
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2007
9	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 08/2013
9	Troponin T (Troponin T1)IBA 11/2021 - 11/2011
9	AlbuminsIBA 06/2021 - 11/2006
9	Purinergic P1 Receptor AntagonistsIBA 11/2019 - 05/2011
9	MicroRNAs (MicroRNA)IBA 01/2018 - 05/2014
8	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2024 - 01/2021
8	Sodium-Glucose Transport ProteinsIBA 04/2024 - 01/2021
8	Growth Differentiation Factor 15IBA 01/2022 - 08/2013
8	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021 - 07/2007
8	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 11/2019 - 12/2004
7	AdrenomedullinIBA 04/2024 - 06/2011
7	Soluble Guanylyl CyclaseIBA 01/2023 - 03/2013
7	SymportersIBA 01/2023 - 10/2019
7	omecamtiv mecarbilIBA 01/2023 - 01/2016
7	IronIBA 11/2019 - 01/2017
6	Spironolactone (Aldactone)FDA LinkGeneric 05/2024 - 01/2014
6	Cardiac MyosinsIBA 01/2023 - 01/2016
6	TroponinIBA 01/2021 - 11/2011
6	PotassiumIBA 01/2021 - 09/2014
6	Adenosine A1 ReceptorIBA 11/2019 - 05/2011
6	Ferritins (Ferritin)IBA 01/2018 - 04/2013
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2010 - 02/2004
5	finerenoneIBA 05/2024 - 01/2015
5	LigandsIBA 01/2023 - 03/2015
5	Fibroblast Growth Factor-23IBA 01/2022 - 01/2018
5	Transferrin (beta 2 Transferrin)IBA 01/2018 - 04/2013
5	Neprilysin (Neutral Endopeptidase)IBA 01/2017 - 08/2013
5	Valsartan (Vals)FDA Link 01/2016 - 08/2013
5	Galectin 3 (LGALS3)IBA 01/2016 - 09/2009
4	Eplerenone (Inspra)FDA LinkGeneric 05/2024 - 01/2015
4	SeleniumIBA 01/2024 - 01/2020
4	CytokinesIBA 09/2023 - 08/2014
4	Vitamin D FDA LinkGeneric 01/2023 - 06/2011
4	Lipocalin-2IBA 01/2022 - 10/2008
4	ChloridesIBA 12/2021 - 01/2016
4	CholesterolIBA 01/2021 - 08/2006

Therapy/Procedure

89	Therapeutics 05/2024 - 02/2004
32	Patient Readmission 03/2024 - 02/2012
14	Length of Stay 01/2023 - 01/2010
5	Percutaneous Coronary Intervention 04/2024 - 08/2010